• Rebecca Forman, Soleil Shah, Patrick Jeurissen, Mark Jit, and Elias Mossialos.
• London School of Economics & Political Science, United Kingdom.
• Health Policy. 2021 May 1; 125 (5): 553-567.

AbstractDeveloping and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine has garnered immense global interest. Less than a year after COVID-19 was declared a pandemic, several vaccine candidates had received emergency use authorization across a range of countries. Despite this scientific breakthrough, the journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant policy challenges that require a collaborative, global response. We offer a framework for understanding remaining and new policy challenges for successful global vaccine campaigns against COVID-19 as well as potential solutions to address them. Decision-makers must be aware of these challenges and strategize solutions that can be implemented at scale. These include challenges around maintaining R&D incentives, running clinical trials, authorizations, post-market surveillance, manufacturing and supply, global dissemination, allocation, uptake, and clinical system adaption. Alongside these challenges, financial and ethical concerns must also be addressed.Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

9 keywords...

hide…